Daily intraperitoneal injection of orexin-A (1 μmol/kg) at day 0 in mice xenografted with PDX cells and up to the mice sacrifices resulted in a significant decrease in tumor volume (80%), as compared to untreated mice (Figure 7). This evidence concerns the gene HCRT and neoplasm.